About UsGeneEase discovers novel gene therapies for subclinical conditions overlooked by traditional medicine - genetic disorders affecting millions (alcohol intolerance, lactose intolerance, mild autoimmunity) where existing treatments are inadequate or nonexistent.We use computational biology to identify promising therapeutic targets, design gene therapy approaches (AAV, base editing, other modalities), validate mechanisms in silico, and partner with wet labs for experimental confirmation. We file patents and license IP to gene therapy companies for clinical development.Role OverviewLead computational gene therapy development: design therapeutics that can be manufactured, delivered, and clinically translated - not just theoretically promising targets.You'll evaluate targets, design vectors with practical constraints in mind (manufacturability, delivery, immunogenicity), validate in silico, and coordinate academic partnerships for experimental validation.80% computational work, 20% wet lab coordination. You design experimentsâpartners execute them. Critical: You must understand what makes gene therapies succeed or fail in practice, not just in silico.Key ResponsibilitiesTherapeutic Design with Translational Focus (40%)Evaluate genetic targets (genetic clarity, deliverability, market size)Design gene therapy approaches considering practical constraints:Manufacturability: AAV titer requirements, production scalability, purificationDeliverability: Tissue accessibility, dose requirements, injection volumes, immunogenicityRegulatory feasibility: IND pathway, safety assessment, clinical endpoint definitionSelect modality (AAV, base editing, other), vector/delivery system, regulatory elementsOptimize constructs (codon usage, cargo size, tissue specificity)In Silico Validation (40%)Protein modeling: Structure prediction (AlphaFold), molecular dynamics (GROMACS), enzyme kineticsSafety assessment: Biodistribution (PBPK), immunogenicity, off-target predictionTranslational risk assessment: Therapeutic window, dose-response, durability predictionsGenerate validation reports with confidence scores and translational risk flagsLab Partnerships (15%)Identify labs with relevant capabilities (animal models, assays, AAV production)Design experimental protocols considering practical feasibility (realistic timelines, achievable titers, appropriate controls)Analyze results vs. predictions, troubleshoot failures, iterate designsCommunication & IP (5%)Draft manuscripts, patent applications, pharma partner dossiers emphasizing clinical translatabilityRequirementsEducation: PhD in Computational Biology, Bioinformatics, Bioengineering, Systems Biology, or related fields (or MS with 3-5 years experience)Wet Lab Experience: 1-3 years hands-on experience (cloning, cell culture, transfection, assays). Gene therapy experience strongly preferred (AAV/lentivirus production, transduction, functional validation, titer quantification).Gene Therapy Technical: Vector design (AAV serotypes, promoter selection, cargo optimization, CRISPR guide RNAs), tools (Benchling, SnapGene)Gene Therapy Development Mindset:Understand what makes vectors succeed vs. fail in practice (not just in silico)Consider manufacturability, deliverability, and immunogenicity upfrontThink in terms of "Can this be produced at scale? Delivered to target tissue? Tolerated by patients?"Computational: Protein modeling (AlphaFold, Rosetta), molecular dynamics (GROMACS/AMBER), pathway analysis (STRING, Reactome), PBPK modelingProgramming: Python (BioPython, pandas, PyTorch), R (Bioconductor), SQL, Git, Linux/HPCNice-to-HavesGene therapy industry experience: Worked at gene therapy biotech in vector development, process development, or CMC rolesIND-enabling study experience: Familiarity with GLP tox, biodistribution studies, dose escalation strategyAAV manufacturing knowledge: Production optimization, titer improvement, purification troubleshootingAcademic/CRO partnership management: Protocol transfer, feasibility assessment, troubleshootingRegulatory awareness: IND/CTA filings, FDA feedback meetings, clinical endpoint selectionEssential TraitsAutonomous problem-solver with mechanistic thinkingBridges computational predictions with biological realityBuilds tools, not just uses themCommunicates complex work to non-technical stakeholdersWhy Join UsShape the foundation of a product that bridges biology and computation.Collaborate with a global, interdisciplinary team.Flexible, remote-first engagement.Opportunity to see your expertise directly influence product development.Please mention the word **INVINCIBLE** and tag RMjQwNToyMDE6ODAyZDo3ODY5OmE4NjE6N2ExOTo0YWNhOjNkOTE= when applying to show you read the job post completely (#RMjQwNToyMDE6ODAyZDo3ODY5OmE4NjE6N2ExOTo0YWNhOjNkOTE=). This is a beta feature to avoid spam applicants. Companies can search these words to find applicants that read this and see they're human.